Researchers have found that alternative splicing — a process that allows a single gene to code for multiple proteins — appears to be a new potential target for anti-telomerase cancer therapy.
Researchers have found that alternative splicing — a process that allows a single gene to code for multiple proteins — appears to be a new potential target for anti-telomerase cancer therapy.